| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |